Curate Biosciences Adds Mayo Pujols to its Board of Directors
prnewswire.com
news
2022-10-19 15:00:00

Pujols brings extensive cell and gene therapy manufacturing experience to the Curate Board
CARLSBAD, Calif., Oct. 19, 2022 /PRNewswire/ --Â Curate Biosciences, a key enabling technology company for cell therapy manufacturing, today announced that Mayo Pujols, Chief Technical Officer of late-stage gene therapy biotech Rocket Pharmaceuticals, has been appointed to its Board of Directors. Mr. Pujols has worked in biopharmaceutical manufacturing for nearly thirty years including managing cell and gene therapy manufacturing operations for Novartis, Celgene, and Andelyn Biosciences, before joining Rocket as Chief Technical Officer (CTO) and Executive Vice President in July of this year.
